Publications | Lund University Publications

3071 – 3080 of 3081

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+v1001237&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2010
Mark Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
Rydén, Lisa ^LU ; Jirström, Karin ^LU ; Haglund, Monica ; Stål, Olle and Fernö, Mårten ^LU (2010) In Breast Cancer Research and Treatment 120. p.491-498
- Contribution to journal › Article
Mark MicroRNAs and other small silencing RNAs in cancer.
Rovira, Carlos ^LU ; Güida, Maria C and Cayota, Alfonso (2010) In IUBMB Life 62(12). p.859-868
- Contribution to journal › Article
Mark Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
Dillner, Joakim ^LU ; Kjaer, Susanne K ; Wheeler, Cosette M ; Sigurdsson, Kristján ; Iversen, Ole-Erik ; Hernandez-Avila, Mauricio ; Perez, Gonzalo ; Brown, Darron R ; Koutsky, Laura A and Tay, Eng Hseon , et al. (2010) In BMJ: British Medical Journal 341.
- Contribution to journal › Article
Mark Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.
Nilsson, Jeanette ; Helou, Khalil ; Kovács, Anikó ; Bendahl, Pär-Ola ^LU ; Bjursell, Gunnar ; Fernö, Mårten ^LU ; Carlsson, Peter and Kannius-Janson, Marie (2010) In Cancer Research 70. p.2020-2029
- Contribution to journal › Article
Mark Genetic profiles distinguish different types of hereditary ovarian cancer.
Bartuma, Katarina ^LU ; Malander, Susanne ^LU ; Staaf, Johan ^LU ; Karlsson, Anna F ^LU ; Borg, Åke ^LU ; Jönsson, Göran B ^LU and Nilbert, Mef ^LU (2010) In Oncology Reports 24(4). p.885-895
- Contribution to journal › Article
Mark Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen, Kari ^LU ; Harbst, Katja ^LU ; Måsbäck, Anna ^LU ; Jönsson, Göran B ^LU ; Borg, Åke ^LU ; Olsson, Håkan ^LU and Ingvar, Christian ^LU (2010) In Melanoma Research Jul 1. p.266-272
- Contribution to journal › Article
Mark Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
Sällfors-Holmqvist, Anna ^LU ; Wiebe, Thomas ^LU ; Hjorth, Lars ^LU ; Lindgren, Anna ^LU ; Øra, Ingrid ^LU and Moëll, Christian ^LU (2010) In Pediatric Blood & Cancer 55. p.698-707
- Contribution to journal › Article
Mark Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro
Bjurberg, Maria ^LU ; Abedinpour, Parisa ^LU ; Brun, Eva ^LU ; Baldetorp, Bo ^LU ; Borgström, Per ; Wennerberg, Johan ^LU and Kjellén, Elisabeth ^LU (2010) In Nuclear Medicine and Molecular Imaging 44(3). p.165-169
- Contribution to journal › Article
Mark Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
Strand, C ; Falck, A-K ; Jirström, K ^LU ; Malmström, P ^LU ; Rydén, L ^LU ; Bendahl, P-O ^LU and Fernö, M. ^LU (2010) In Cancer Research 70(24 Supplement).
- Contribution to journal › Published meeting abstract
Mark Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
Vickers, Andrew J. ; Cronin, Angel M. ; Björk, Thomas ^LU ; Manjer, Jonas ^LU ; Nilsson, Peter M. ^LU ; Dahlin, Anders ^LU ; Bjartell, Anders ^LU ; Scardino, Peter T. ; Ulmert, David ^LU and Lilja, Hans ^LU (2010) In BMJ (Online) 341(7773).
- Contribution to journal › Article

your query:: Remove department: BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation